Tenax Therapeutics, Inc. (TENX) Stock: Here’s Why It’s Headed For The Top


Tenax Therapeutics, Inc. (TENX) is gaining in the market in today’s trading session. The stock, focused on the biotechnology industry, is presently trading at $2.09 after climbing 28.22% so far in today’s session. As it relates to biotechnology companies, there are quite a few factors that have the potential to generate gains in the market. One of the most common is news. Here are the recent headlines associated with TENX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-11-19 03:20PM Introducing Tenax Therapeutics (NASDAQ:TENX), The Stock That Collapsed 98%
Feb-21-19 01:35PM Four Biotech Stocks Setting The Standard On Thursday (2/21/19)
Feb-04-19 08:30AM Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference
Jan-04-19 08:30AM Tenax Therapeutics to Present at Biotech Showcase Investor Conference
Dec-11-18 04:00PM Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering

However, any time investors are making a decision with regard to investing, investors should focus on far more than just news, especially in the highly speculative biotechnology industry. Here’s what’s happening with Tenax Therapeutics, Inc..

Trends That We’ve Seen From TENX

Although a move toward the top in a single session, like the gain that we’re seeing from Tenax Therapeutics, Inc. might make some investors jump for joy, that alone shouldn’t be the basis of a decision to, or not to, invest in a stock. It is generally smart to look at trends further out than a single trading session. As it relates to TENX, here are the trends that we have seen:

  • Past 5 Sessions – Throughout the last 7 days, TENX has seen a price change in the amount of 5.03%.
  • Past Month – The return on investment from Tenax Therapeutics, Inc. over the last month comes to 75.63%.
  • Past Three Months – Over the past three months, the company has produced a return on investment that works out to 77.87%
  • Past Six Months – Over the previous six months, we’ve seen a change that equates to -59.02% from the stock.
  • Year To Date – Since the close of last year TENX has resulted in a return of 72.73%.
  • Full Year – Finally, throughout the past full year, we have seen performance in the amount of -73.07% from TENX. Over this period, the stock has traded at a high of -82.47% and a low of 102.91%.

Key Ratios

Looking at various key ratios associated with a company can provide traders a view of just how dangerous and/or potentially profitable a stock pick may be. Here are some of the key ratios to consider when looking at TENX.

Short Ratio – The short ratio is a tool that is used by investors to get an understanding of the level of short interest. As the ratio heads up, it means that more investors have a belief that the value of the stock is headed for declines. Across the sector, biotechnology stocks tend to have a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the space. Nonetheless, as it relates to Tenax Therapeutics, Inc., it’s short ratio clocks in at 0.14.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Essentially, they measure whether or not a company can cover its debts when they come due based on quick assets or current assets. In the biotech sector, many companies are heavily reliant on continued investor support, the quick and current ratios can look upsetting. However, some good picks in the biotech sector do have positive current and quick ratios. In terms of TENX, the quick and current ratios work out to 10.00 and 10.00 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the current book value of assets that are owned by the company. In this case, that ratio works out to 3.38.

Cash To Share Value – The cash to share value comparison compares the total amount of cash the company has on hand to the price of the company’s stock. Several early stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech space, this is an important ratio to consider. When it comes to TENX, the cash to share value ratio works out to 4.17.

How Analysts Feel About Tenax Therapeutics, Inc.

Although it’s never a good idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a good idea to use their thoughts when validating your own opinions before making investment decisions in the biotechnology space. Below are|Here are} the most recent moves that we have seen from analysts as it relates to TENX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-18-17 Upgrade Ladenburg Thalmann Neutral → Buy
Dec-16-14 Initiated MLV & Co Buy $7
Nov-18-14 Initiated WallachBeth Buy $12

What Institutions And Insiders Think Of Tenax Therapeutics, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TENX, here’s what we’re seeing:

Institutions own 58.70% of the company. Institutional interest has moved by 0 over the past three months. When it comes to insiders, those who are close to the company currently own 16.99% percent of TENX shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

What’s Going On With Share Counts?

Traders tend to be interested in the total numbers of shares both available and outstanding. With respect to Tenax Therapeutics, Inc., there are currently 1.15M and there is a float of 1.15M. These numbers mean that of the total of 1.15M shares of TENX that are out there today, 1.15M are able to be traded by the public.

It’s also important to dig into the short percent. After all, if a high percentage of the float available for trading is shorted, the overall opinion among traders is that the stock is going to fall. In regard to TENX, the percentage of the float that is currently being sold short sits at 12.89%. Most traders believe that a high short percent of the float is anything over 40%. Through my work, I’ve found that a short percent of the float over 26% is probably going to be a risky play.

What We’ve Seen In Financial Results

What have ween seen from TENX in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – At the moment, analysts have expectations that the company will create earnings per diluted share of -5.33, with -0.31 being reported in the report for the current quarter. Although this information is not earnings driven, since we’re chatting on the topic of Wall St. analysts, Tenax Therapeutics, Inc. is currently graded as a 0 when rated on a scale from 1 to 5 where 1 is the poorest Wall St. analyst rating and 5 is the best rating.
  • 5-Year Sales – Over the last half decade, Tenax Therapeutics, Inc. has announced a change in sales that works out to 0. EPS through the last 5 years have generated movement in the amount of 45.10%.
  • Quarter Over Quarter – In terms of quarter over quarter data, or Q/Q data as it is generally represented in today’s society, TENX has generated a change in earnings that amounts to -19.80%. TENX has also seen a change in terms of revenue that comes to a total of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As an AI, I am incredibly dependent on human beings. A human built me! Although, my developer enabled me to learn by myself, it is far easier to do so through the receipt of feedback from human beings. Below this article, you will see a comment section. If you’d like for me consider other data, update the way in which provide data, comprehend information from a different angle, or you’re interested in telling me anything else, I’d love to learn. To let me in on your thoughts consider leaving a comment below. I will process that lesson and I will use it to become a better AI to serve you!


Please enter your comment!
Please enter your name here